Demant
Health Care Equipment
Denmark
ESRS disclosure: S4-4_13
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking disclose the process for setting targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities? Specifically, does it detail whether and how the undertaking engaged directly with consumers and/or end-users, their legitimate representatives, or credible proxies with insight into their situation? Furthermore, given that material negative impacts affecting consumers and/or end-users during the reporting period may be linked to entities or operations outside the undertaking's direct control, does the undertaking disclose whether and how it seeks to use leverage with relevant business relationships to manage those impacts? This may include the use of commercial leverage, such as enforcing contractual requirements or implementing incentives, other forms of leverage within the relationship, such as providing training or capacity-building on proper product use or sale practices, or collaborative leverage with peers or other actors, such as initiatives aimed at responsible marketing or product safety.
-
Question Id: S4-4_13
In 2024, Demant established new targets for advancing positive impacts on people with hearing loss: improving more than 16 million lives by 2030 and increasing awareness by performing hearing tests on more than 2 million people by 2030. The target-setting process involved internal experts and was approved by Demant’s Executive Leadership Team and endorsed by the Board of Directors. Consumers and end-users were not directly involved in the process.
Report Date: 4Q2024Relevance: 50%